List of post by tag

Anne DeGheest on Where the Action is Heading in Healthcare: Delivery, Delivery, Delivery

On April6, 2011 in Xconomy, Luke Timmerman published a nice article on our efforts with HealthTech Capital:     Talking with the angel investor Anne DeGheest the other day was humbling. After all, I sweat out long days and nights digging up news and features on what I think often represents the leading edge in healthcare capitalism—new drugs, medical devices, diagnostics, etc.

All that innovation is worthy of attention—she apparently didn’t want to hurt this biotech scribe’s feelings too much—but if you really want to find where the action is heading in healthcare, DeGheest insists it’s in something she likes to call “healthtech.”

What DeGheest is talking about is sort of a catch-all for healthcare delivery technologies that used to be what venture capitalists considered the boring part of healthcare. New drugs and devices represent about 16 percent of the total $2.5 trillion U.S. healthcare market, she says, while the rest of the market is focused on the delivery side of healthcare, like the everyday transactions that happen at hospitals and clinics. Now that President Obama’s healthcare reform effort is the law, and most everyone agrees that healthcare costs need to be somehow corralled, it’s time for a wave of innovative new healthtech companies that are focused on improving care and reducing costs—not adding new costs like with all those innovative drugs and devices.

“Venture capital and entrepreneurship have been focused on drugs and devices for 20 years,” DeGheest says. “I want to look at the other 84 percent of the market. Several forces are coming together at same time, to change the way we practice healthcare in this country, in a way more cost efficient way.”

Read more →

Anne DeGheest | 06 April 2011

Angels, VCs Come Together to Back Health-Care Tech Makers

On March 11, 2011, Timothy Hay, from Venture Wire, wrote the following article on VC Funds News:
A group of Silicon Valley venture capitalists, angel investors, corporations and health-care providers have banded together to invest in companies that assist in the delivery of health care, a market some investors say has been woefully underserved.

 "I've been a lonely pioneer in funding health-care technology," said Anne DeGheest, a founder and managing director of newly formed HealthTech Capital, who is also a managing partner at MedStars Venture Partners, a two-person early-stage firm with an emphasis on health care.

Read more →